Volume 30, Number 2—February 2024
Dispatch
Rebound of Gonorrhea after Lifting of COVID-19 Preventive Measures, England
Holly Fountain1
, Stephanie J. Migchelsen1, Hannah Charles, Tika Ram, Helen Fifer, Hamish Mohammed, and Katy Sinka
, Stephanie J. Migchelsen1, Hannah Charles, Tika Ram, Helen Fifer, Hamish Mohammed, and Katy Sinka
Table 1
Numbers of persons with gonorrhea diagnoses who attended sexual health services according to gender and sexual orientation in study of rebound of gonorrhea after lifting of COVID-19 preventive measures, England*
| Year | No. persons with gonorrhea diagnosis |
||||
|---|---|---|---|---|---|
| MSM | Heterosexual men | WSM | WOSW | Not known | |
| 2019 | |||||
| Quarter 1 | 7,851 | 3,678 | 4,280 | 44 | 889 |
| Quarter 2 | 8,341 | 3,692 | 4,205 | 64 | 1,005 |
| Quarter 3 | 9,249 | 3,832 | 4,498 | 55 | 1,152 |
| Quarter 4 |
8,466 |
3,909 |
4,757 |
47 |
1,119 |
| 2020 | |||||
| Quarter 1 | 8,040 | 3,356 | 3,883 | 60 | 1,005 |
| Quarter 2 | 4,352 | 1,681 | 1,962 | 39 | 580 |
| Quarter 3 | 6,194 | 2,436 | 2,832 | 59 | 956 |
| Quarter 4 |
6,491 |
2,585 |
2,964 |
69 |
1,134 |
| 2021 | |||||
| Quarter 1 | 5,184 | 2,041 | 2,392 | 52 | 1,305 |
| Quarter 2 | 5,251 | 1,674 | 2,076 | 77 | 1,456 |
| Quarter 3 | 7,107 | 2,152 | 2,577 | 69 | 1,810 |
| Quarter 4 |
8,724 |
2,674 |
3,665 |
85 |
4,590 |
| 2022 | |||||
| Quarter 1 | 8,809 | 2,916 | 3,809 | 109 | 2,419 |
| Quarter 2 | 9,684 | 3,224 | 4,182 | 127 | 2,560 |
| Quarter 3 | 10,498 | 3,684 | 5,032 | 115 | 2,953 |
| Quarter 4 | 9,932 | 4,097 | 5,274 | 123 | 3,045 |
*Preventive measures were lifted in July (quarter 3) of 2021. MSM, gay, bisexual and other men who have sex with men; WOSW, women who only have sex with women; WSM, women who have sex with men.
1These first authors contributed equally to this article.
Page created: November 30, 2023
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.